National Cancer Institute Research Identifies Unique Mechanism of Brostallicin's Anti-Tumor Effectiveness

... other currently used chemotherapy agents. CTI acquired worldwide rights to brostallicin when it acquired privately-held Systems Medicine LLC in 2007. ... Systems Medicine (SM) In July 2007, CTI acquired Systems Medicine, a privately-held oncology ...

Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development

... protection. About SCH 900795 Nobilon acquired in 2004 the majority of rights to develop, ... from Australian company BioDiem, which had acquired these rights from the Institute of Experimental ... Corporation, was founded in 2003 and was acquired through the Organon BioSciences acquisition in ...

First Molecular Tem-PCR Test to Identify Multiple Forms of Staph and MRSA Obtains CLIA Certificate

... receive Medicare reimbursement for many hospital acquired infections. Prior to the Tem-PCR molecular ... (CAI) in a single molecular test. Unlike hospital acquired MRSA which affects patients in a ... decides to deny reimbursement for hospital acquired infections after October 1." Jian Han, M.D., ...

Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKline's Rotarix(R)

... terms of this agreement, Paul Capital Healthcare acquired all royalties on worldwide sales of Rotarix(R) ... In November 2005, Paul Capital Healthcare acquired an interest in Rotarix(R) from three inventors at Cincinnati Children's; and in May 2005 acquired a portion of AVANT Immunotherapeutics' total ...

Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus

... European Product Line for Healthcare acquired Infections SUNNYVALE, Calif., Dec. 4 ... of two leading causes of hospital and community acquired infections -- Methicillin Resistant ... "The incidence of both hospital and community acquired MRSA and SA infections have been shown to be ...

Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial

... Foley Catheters." Conway continued, "Hospital acquired infections are a serious problem across the ... for Disease Control estimates 40% of all hospital acquired infections are urinary tract infections resulting ... catheters." Conway also noted, "Hospital acquired infections are coming under heightened scrutiny, ...

Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs

... milestones in advancing its pipeline of novel antibodies since being acquired by Lilly less than a year ago. One of those molecules, IMC-1121B, already ... today, ImClone has made several advancements in its pipeline since being acquired by Lilly. Highlights include: IMC-11F8 is expected to move ...

Advanced Life Sciences Announces Outcome of FDA's Anti-Infective Drugs Advisory Committee Review of Restanza(TM) (cethromycin)

... for the outpatient treatment of adults with mild-to-moderate community acquired pneumonia (CAP) (11 positive, 3 negative, 1 abstaining). However, the ... not yet approved for this or any other indication. About Community acquired Pneumonia (CAP) CAP is the sixth most common cause of death in the ...

Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease

... and acute inflammatory diseases and autoimmune disorders. The Company has acquired from Eli Lilly and Company and Shionogi & Co.¿ Ltd. worldwide rights ... have the potential to address a variety of diseases. The company has also acquired exclusive and worldwide rights to a peptide fusion protein, A-623, for the ...

GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America

... AIDS vaccines are designed to prevent HIV-1 virus infection which causes acquired Immunodeficiency Disease (AIDS). The Seattle meeting also achieved ... GeoVax AIDS vaccines are designed for use in uninfected people to prevent acquired Immunodeficiency Disease (AIDS), caused by the virus known as HIV-1, ...

Lutonix Inc. Announces $20 Million Series B Financing

... biotechnology and pharmaceuticals. The firm's portfolio companies include acquired companies such as Eyeonics, Intralase, Lipsonix, NovaCardia, Pharmion, ... companies have either completed an initial public offering or have been acquired by a leading healthcare corporation. U.S. Venture Partners is a leading ...

Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia

... Phase II clinical trial evaluating NXL103 in the treatment of community acquired pneumonia (CAP). NXL103 is a novel oral streptogramin antibiotic that has ... structure infections, including those caused by MRSA, as well as community acquired pneumonia. Novexel's future clinical development with NXL103 is expected ...

Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)

... of new potential therapeutic indications, including NASH, under licenses acquired from UCSD. Cysteamine has demonstrated potential efficacy in preclinical ... December 2007 acquisition of Encode Pharmaceuticals. In March 2008, Raptor acquired an exclusive worldwide license to intellectual property from UCSD for the ...

Doctor Declares War on Hospital Infections, Patents MRSA-Killing Machine

... 450-bed regional hospital. Almost fifteen percent, 2,012 patients, acquired an infection. The average length of stay for infected patients increased ... expanded Medicare rules will hold hospitals accountable and liable for acquired infections, costing millions of dollars in non-reimbursed funds. The ...

Variant of Mad Cow Disease May Be Transmitted by Blood Transfusions, According to Animal Study

... were experimentally infected, while the scrapie donors had naturally acquired the disease. While scrapie is not thought to transmit to humans, it was ... were consistent with what is known about the four recorded cases of vCJD acquired by blood transfusion in humans. In addition to the stage of infection in ...

Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease

... provide funding and clinical supply of Cysteamine. In March 2008, Raptor acquired an exclusive, worldwide license to certain intellectual property and ... its December 2007 merger of Encode Pharmaceuticals. In March 2008, Raptor acquired an exclusive, worldwide license to the intellectual property and ...

Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)

... are causative pathogens for respiratory tract infections such as community acquired pneumonia (CAP). The CA-MRSA strain can attack and destroy white blood ... boils but CA-MRSA can also cause respiratory infections such as community acquired pneumonia. Macrolides and clindamycin are currently the front-line ...

European Union's CHMP Issues Positive Opinion on Sugammadex

... (impairment of the sense of taste) (12.6 percent). Schering-Plough acquired sugammadex through its combination with Organon BioSciences on November ... as well as to animal health products. In November 2007, Schering-Plough acquired Organon BioSciences, with its Organon human health and Intervet animal ...

Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting

... and enter the U.S. oncology market. In October 2006, Eisai acquired four products mainly for the treatment of cutaneous T-cell lymphoma, as ... antibody technology and an antibody pipeline. In January 2008, Eisai acquired MGI PHARMA, INC., an oncology and acute care-focused company, to broaden ...

FDA Advisory Committee Unanimously Recommends U.S. Approval of Sugammadex, the First and Only Selective Relaxant Binding Agent

... when immediate reversal of rocuronium is needed. Schering-Plough acquired sugammadex through its combination with Organon BioSciences on November ... as well as to animal health products. In November 2007, Schering-Plough acquired Organon BioSciences, with its Organon human health and Intervet animal ...

Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin

... New Drug Application (NDA) submission for cethromycin to treat community acquired pneumonia (CAP). The U.S. Food and Drug Administration (FDA) requires ... 617-801-6888 (international), passcode 10008184. About Community acquired Pneumonia (CAP) CAP is the sixth most common cause of death in the ...

New Study Results Show Asenapine More Effective Than Placebo in the Treatment of Acute Schizophrenia

... become socially withdrawn, fearful, and agitated (2). Schering-Plough acquired asenapine through its combination with Organon BioSciences on November 19, ... as well as to animal health products. In November 2007, Schering-Plough acquired Organon BioSciences, with its Organon human health and Intervet animal ...

Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA

... mania trials involving nearly 3,000 patients. Schering-Plough acquired asenapine through its combination with Organon BioSciences on November 19, ... as well as to animal health products. In November 2007, Schering-Plough acquired Organon BioSciences, with its Organon human health and Intervet animal ...

Obesity Common in Children with Heart Disease

... life expectancy. More than 25 percent of children with congenital and acquired heart disease are overweight or obese, say researchers from The ... outpatient care in 2004. Of the 2,921 samples, 1,523 children had either acquired or congenital heart disease. Roughly half of the sample who had no ...

Seal Shield Launches World's First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control

... a US hospital. Of those, close to 100,000 people will die, making hospital acquired infections a Top 10 killer of Americans. Complicating this epidemic, a ... on computer keyboards for up to 6 weeks. The recent rise in hospital acquired infections, and the lack of an effective treatment for MRSA, has prompted ...

Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy

... against key susceptible and resistant pathogens involved in community acquired pneumonia (CAP), while others reviewed safety data in certain special ... the emerging bacterial resistance observed in the treatment of community acquired pneumonia (CAP). Cethromycin has been tested in approximately 5,000 human ...

Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza

... including the effect of stock compensation expense and the amortization of acquired intangibles for 2007, is expected to remain in the range of $8 million to ... year of 2008, excluding stock compensation expense and the amortization of acquired intangibles." About Cepheid Cepheid (Nasdaq: CPHD ), based in ...

Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy

... against key susceptible and resistant pathogens involved in community acquired pneumonia (CAP), while others reviewed safety data in certain special ... the emerging bacterial resistance observed in the treatment of community acquired pneumonia (CAP). Cethromycin has been tested in approximately 5,000 human ...

Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy

... for the analysis of melanocytic lesions," Dr. Pellacani continued. Images acquired from Lucid VivaScopes(R) in 5 to 10 minutes "The images in this study were acquired using VivaScope(R) confocal microscopes developed and manufactured by ...

Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program

... These statements include those relating to: clinical trial plans and timelines and clinical results for ProLindac and product candidates acquired in the MacroChem transaction, our ability to execute licensing agreements in the future, Access' plans to continue and initiate clinical trials, the ...

FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia

... schizophrenia and manic episodes associated with bipolar I disorder. The application will follow the Centralized Procedure. Schering-Plough acquired asenapine in November 2007 through its acquisition of Organon BioSciences, which developed the product. About Schizophrenia ...

Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study

... control of costs and expenses; our ability to obtain and maintain adequate intellectual property protection; our ability to successfully integrate acquired businesses; our ability to form and implement alliances; challenges relating to changes in and compliance with governmental laws and regulations ...

Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis

... These statements include those relating to: clinical trial plans and timelines and clinical results for ProLindac and product candidates acquired in the MacroChem transaction, our ability to execute licensing agreements in the future, Access' plans to continue and initiate clinical trials, the ...

Leading Experts Endorse Bioheart's Muscle Stem Cell MyoCell Therapy

... and reduce our expenses; (iii) our ability to establish a distribution network for and commence distribution of certain products for which we have acquired distribution rights; (iv) our ability to timely and successfully complete our clinical trials; (v) the occurrence of any unacceptable side effects ...

GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting

... technology is the subject of 20 issued or filed patent applications. GeoVax AIDS vaccines are designed for use in uninfected people to prevent acquired Immunodeficiency Disease (AIDS), caused by the virus known as HIV-1, should the person ever become infected. GeoVax AIDS vaccines also may be ...

Alfacell Provides Shareholder Update

... previously treated with chemotherapy who received the combination of Onconase and doxorubicin points to molecular mechanisms of inherent or acquired chemotherapy resistance. It is known that there are specific chemotherapy resistance genes which not only are present in untreated mesotheliomas but ...

Study Demonstrates Efficacy of Pitavastatin in Elderly Patients

... a specialty pharmaceutical company focused primarily in the area of cardiology. The company, started in 2001 as ProEthic Pharmaceuticals, Inc., was acquired by Kowa Company, Ltd. in September of 2008. A privately held company, KPA focuses its efforts on the acquisition, development, licensing and ...

Heparin Use Prior to Endoscopic Vein Harvest Improves Graft Patency in Off-Pump Coronary Artery Bypass Patients

... of Cardiac Surgery, Boston University . The prospective study examined acute patency rates in 460 patients that underwent OPCAB using veins acquired through EVH, comparing patients receiving no heparin prior to harvest (n=306) to those who received one of three doses of heparin prior to the ...

Access Pharmaceuticals Announces Publication of Thiarabine Combination Data

... These statements include those relating to: clinical trial plans and timelines and clinical results for ProLindac and product candidates acquired in the MacroChem transaction, our ability to execute licensing agreements in the future, Access' plans to continue and initiate clinical trials, the ...

IMPACT Study Showed Longer Valcyte(R) (valganciclovir hydrochloride tablets) Treatment Demonstrated Better Protection Against Cytomegalovirus (CMV) Disease One Year Post-Transplant

... the mortality rate can be as high as 90%. About Valcyte Valcyte tablets are indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS). Valcyte is indicated for the prevention of CMV disease in kidney, heart, and kidney-pancreas transplant patients at ...